AFT Pharmaceuticals Limited (ASX:AFP)
Australia · Delayed Price · Currency is AUD 2.710
-0.140 (-4.91%)
Nov 13, 2025, 10:14 AM AEST
AFT Pharmaceuticals Market Cap
AFT Pharmaceuticals has a market cap or net worth of 294.14 million as of November 13, 2025. Its market cap has decreased by -5.66% in one year.
Market Cap
294.14M
Enterprise Value
310.00M
Revenue
189.03M
Ranking
n/a
PE Ratio
27.06
Stock Price
2.71
Market Cap Chart
Since December 22, 2015, AFT Pharmaceuticals's market cap has increased from 282.68M to 294.14M, an increase of 4.05%. That is a compound annual growth rate of 0.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 294.14M | 6.87% |
| Dec 31, 2024 | 275.23M | -19.28% |
| Dec 29, 2023 | 340.95M | -4.96% |
| Dec 29, 2022 | 358.75M | -18.74% |
| Dec 31, 2021 | 441.47M | -17.88% |
| Dec 31, 2020 | 537.56M | 64.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.09B |
| Pro Medicus | 26.64B |
| Cochlear | 18.86B |
| Sonic Healthcare | 10.41B |
| Ramsay Health Care | 7.04B |
| Telix Pharmaceuticals | 5.29B |
| Ansell | 5.22B |
| Mesoblast | 2.96B |